Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4

Cancer Medicine
Xu ZhangBen Liu

Abstract

The aim of this study is to investigate the functions and mechanisms of miR-608 in prostate cancer (PCa). CISH and qRT-PCR analysis demonstrated that miR-608 was low expressed in PCa tissues and cells, which was partly attributed to the methylation of CpG island adjacent to the transcription start site (TSS) of miR-608 gene. Intracellular miR-608 overexpression inhibited in vivo PCa tumor growth, and suppressed PCa cell proliferation, G2/M transition, and migration in vitro, which was independent of EMT-associated mechanisms. Then RAC2, a GTPase previously deemed hematopoiesis-specific but now discovered to exist and play important roles in PCa, was verified by western blot and dual-luciferase reporter assays to mediate the effects of miR-608 through RAC2/PAK4/LIMK1/cofilin pathway. MiR-608 also promoted the apoptosis of PCa cells through BCL2L1/caspase-3 pathway by targeting the 3'-UTR of BCL2L1. Moreover, PAK4, the downstream effector of RAC2, was found to be targeted by miR-608 at the mRNA coding sequence (CDS) instead of the canonical 3'-UTR. Knocking down RAC2, PAK4, or BCL2L1 with siRNAs reproduced the antiproliferative, mitosis-obstructive, antimigratory and proapoptotic effects of miR-608 in PCa cells, which could be at...Continue Reading

References

Jan 1, 1995·Cell Motility and the Cytoskeleton·R NagaokaT Obinata
Oct 23, 2001·The Journal of Biological Chemistry·Marinella G CallowTod Smeal
Jun 25, 2003·The Journal of Biological Chemistry·Monica DavilaRatna Chakrabarti
May 4, 2005·Cancer Research·Richard I Gregory, Ramin Shiekhattar
Sep 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Harris S SoiferPål Saetrom
Dec 15, 2007·The Journal of Biological Chemistry·Noriko KajiKensaku Mizuno
Apr 22, 2008·Cellular Signalling·Tasneem AhmedClaire M Wells
Jan 23, 2009·Journal of Cell Science·Jacco van RheenenMichael Glogauer
Sep 2, 2010·The Journal of Cell Biology·Guillaume BompardNathalie Morin
Sep 30, 2010·The Journal of Cell Biology·Rebecca W ScottMichael F Olson
Oct 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michelle K Y SiuAnnie N Y Cheung
Mar 23, 2011·Mutation Research·Tanja KunejGeorge Adrian Calin
May 18, 2011·Genes & Development·Aimée M Deaton, Adrian Bird
Sep 7, 2011·Cellular Signalling·Eva WertheimerMarcelo G Kazanietz
Mar 2, 2013·Nature Reviews. Drug Discovery·Sarah Crunkhorn
May 28, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Min Kyung JooKwangmeyung Kim
Apr 28, 2017·British Journal of Haematology·Meike VoglerMartin J S Dyer
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shuangshuang WuMinjie Chu
Oct 28, 2017·International Journal of Oncology·Norahayu Othman, Noor Hasima Nagoor
Nov 15, 2017·Nature Reviews. Urology·Solomon L WolduVitaly Margulis
Jun 30, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Huan XiaXiaohong Lv
Oct 10, 2018·Nature Structural & Molecular Biology·Kai ZhangXiang-Dong Fu

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
transfection
PCR
xenograft
flow cytometry
Flow
GTPases

Software Mentioned

pmirGLO
FlowJo
ModFit

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Actin, Myosin & Cell Movement

Contractile forces generated by the actin-myosin cytoskeleton are critical for morphogenesis, but the cellular and molecular mechanisms of contraction have been elusive for many cell shape changes and movements. Here is the latest research on the roles of actin and myosin in cell movement.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis